We're supporting research and development, and working to make sure that any new vaccines, tests and treatments are mass-produced quickly and reach everyone who needs them.
We’re doing this by working with others:
Governments and international organisations must invest now in research and development of diagnostics, treatments and vaccines. And they must support fair access to these lifesaving tools – so they become available to the most at-risk populations everywhere, regardless of ability to pay.
To achieve this, $31 billion is needed over the next 12 months. Investing now, at scale and as a collective global effort, is the only way to save lives, reduce the spread of Covid-19 and bring societies and economies back on track.
The true impact of the Covid-19 pandemic will be felt beyond its immediate effects. Jeremy Farrar explains why the choices leaders make now will help define the 21st century.
Covid-19 is already causing wider consequences for societies, national economies and global relations, and these will continue for years to come. Three experts share insights on how we can better respond to the pandemic.
[Summary] A commitment by Wellcome, UNICEF, the WHO, and the World Economic Forum to embed three principles across our mental health work: lived experience, local innovation, and larger than healthcare.
[Summary] This report presents the results of the fifth Wellcome Monitor. It focuses on findings about Covid-19.
[Summary] A roadmap to making lifesaving monoclonal antibody treatments affordable and available, particularly to those living in low- and middle-income countries.
[Summary] Our polling of more than 6,000 adults in the UK, the USA, Germany and France shows strong public support for making sure that any new coronavirus treatments and vaccines are first made available to those who need them most.